RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. SV Health Investors
S

SV Health Investors portfolio

SV Health Investors has 9 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.

Type: Venture capital.
Portfolio on Recent Funding: 9.
Deals, last 12 months: 2.
Rounds led: 4 of 12.
Capital in their rounds: $1.2B.
Latest deal: OMass Therapeutics · Oct 15, 2026.
About this page

It is a venture capital firm based in London, GB, founded in 2013. It led 4 of the 12 rounds it joined. Its most recent investment on record is OMass Therapeutics's $310M Series B+ round in October 2026, alongside Jefferson Life Sciences, Novo Holdings, Janus Henderson Investors and 6 others. By category, its portfolio leans toward Health and bio (9) and Manufacturing and industrial (1). It has co-invested with Sanofi Ventures, Johnson & Johnson Innovation and F-Prime Capital, most often Sanofi Ventures (5 rounds).

About SV Health Investors

Firm type: Venture capital.
Headquarters: London, GB.
Founded: 2013.
Stages: Seed, Series A, Series B, Series C, Growth, Late Stage.
Sectors: Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
Check size: $1M to $20M.
Leads rounds: Yes.
Portfolio companies: 208.
Exits: 6.
Rounds led: 4.

Fund returns

FundVintageSizeNet IRRTVPIDPIAs of
SV Health Investors Growth Fund VII b2024—0.0%0.00x0.00xJun 30, 2025

What SV Health Investors invests in

SV Health Investors recent investments

CompanyRoundDateAlongside
OOMass TherapeuticsSeries B+ · $310MJefferson Life Sciences, Novo Holdings (lead), Janus Henderson Investors +6
AAdvanCellSeries B+ · $315MFidelity Management & Research Company, Morningside, Eli Lilly +15
DDraig TherapeuticsSeed · $140M · leadIntermediate Capital Group (lead)
TTherini BioSeries A · $39MApollo Health Ventures, Eli Lilly, Dolby Family Ventures +5
AAdvanCellSeries B+ · $112M · leadMorningside, Abingworth (lead), SymBiosis (lead) +3
RRia HealthSeries B+ · $7MPeloton Equity (lead), SOSV, BPEA
PPulmocideSeries B+ · $52MPictet Alternative Advisors (lead), Longwood Fund, Johnson & Johnson Innovation +6
RRia HealthSeries A · $18M · leadSOSV SF & NY, EQT Private Capital Asia, SOSV

How SV Health Investors invests

StageDealsCapital in rounds
Series B+ 7 58%$918.4M
Series A 3 25%$124M
Seed 2 17%$157M
YearDealsCapital in rounds
2017 1 8%$30.4M
2021 2 17%$109M
2022 3 25%$137M
2025 4 33%$298M
2026 2 17%$625M

SV Health Investors portfolio companies

CompanyRound with SV Health InvestorsTotal raisedLatest raise
OOMass Therapeutics
Health and bio
Series B+ · $310M$422.51MOct 15, 2026
Series B+
AAdvanCell
Health and bio
Series B+ · $315M$439.5MJul 15, 2026
Series B+
DDraig Therapeutics
Health and bio
Seed · $140M · lead$205MJul 14, 2026
Series B+
TTherini Bio
Health and bio
Series A · $39M$56MMay 21, 2026
Series A
RRia Health
Health and bio
Series B+ · $7M$25MFeb 1, 2025
Series B+
PPulmocide
Health and bio
Series B+ · $52M$174.4MDec 6, 2022
Series B+
RRondo Therapeutics
Health and bio
Series A · $67M$67MMar 2, 2022
Series A
EEnara Bio
Health and bio
backer$32.5MJun 2, 2026
Series B+
LLoQus23
Health and bio
backerundisclosedOct 2, 2024
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Net returns as reported by the public-pension and foundation LPs invested in each fund.

Firm profile and fund returns: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 12 rounds on Recent Funding that name SV Health Investors. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists SV Health Investors, which is a subset of its real portfolio. API: /api/v1/investors/sv-health-investors (get a free API key). More: the most active VC firms and new venture capital funds.